The efficacy of oral cyproterone acetate in combination with ethinyloestradiol in acne tarda of the facial type

Journal of Dermatological Treatment

Volumn 9, Issue 2, 1998, Pages 71-79

  Gollnick, H ^a   Albring, M ^b   Brill, K ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

Acne tarda; Antiandrogen; Cyproterone acetate; Facial acne; Seborrhoea

Indexed keywords

ANTIANDROGEN; CONTRACEPTIVE AGENT; CYPROTERONE ACETATE; DIANE; ETHINYLESTRADIOL;

ACNE; ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CLINICAL TRIAL; COMEDO; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HIRSUTISM; HUMAN; MAJOR CLINICAL STUDY; MASTALGIA; MULTICENTER STUDY; NAUSEA; NERVOUSNESS; ORAL DRUG ADMINISTRATION; PAPULE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUSTULE; SEBORRHEA; SIDE EFFECT; SKIN CYST; VERTIGO; VIRILIZATION;

EID: 0031879755     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.3109/09546639809161376     Document Type: Article

References (23)

1. Cunliffe WJ, Acne. Martin Dunitz: London, 1989.
2. Gollnick H, Zouboulis Ch, Akamatsu H et al, Pathogenesis and pathogenesis related treatment of acne. J Dermatol (1991) 18: 489-99.
3. Plewig G, Kligman AM, Acne and rosacea, 2nd edn. Springer Verlag: Berlin, Heidelberg, New York, 1993.
4. Thiboutot DEM, Knaggs H, Gilliland K, Hagari S, Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis. Br J Dermatol (1997) 136: 166-71.
5. Cunliffe WJ, Forster RA, Androgen control of the pilosebaceous duct? Br J Dermatol (1987) 116: 449.
6. Strauss JS, Pochi PE, The human sebaceous gland: its regulation by steroidal hormones and its use as an end organ for assaying androgenicity in vivo. Recent Progr Hormone Res (1963) 19: 385-444.
7. Takayasu S, Wakimoto H, Itami S, Sano S, Activity of testosterone 5α-reductase in various tissues of human skin. J Invest Dermatol (1980) 75: 187-91.
8. Thiboutot DEM, Harris G, Isles V et al. Activity of the type 1 5α-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol (1995) 105: 209-14.
9. Downing DT, Steward ME, Wertz PE et al, Essential fatty acids and acne. J Am Acad Dermatol (1996) 14: 221-5.
10. Aydinlik S, Lachnit-Fixson U, Lehnert J, Oestrogen reduced ovulation inhibitors for the treatment of acne. Double-blind comparative study of Diane 35 and Diane. Fortschr Med (1986) 104: 547-50.
11. Bossemeyer RP, Aquiar LF, Andrade RP et al, Multicenter open study on monophasic gestodene and ethinylestradiol in teenagers. Gynecol Endocrinol (1993) 7: 8-13.
12. Bruchowsky N et al. Molekulare Wirkung von Androgenen und Antiandrogenen. In: Hammerstein J et al (eds) Androgenisierungserscheinungen bei der Frau. Excerpta Medica: Amsterdam, Oxford, Princeton, 1979, pp 7-21.
13. Burton J et al. Reduction of sebum excretion in man by the antiandrogen cyproterone acetate. Br J Dermatol (1973) 89: 487.
14. Ebling FJ, Thomas AK, Cooke ID et al. Effect of cyproterone acetate on hair growth, sebaceous secretion and endocrine parameters in a hirsute subject. Br J Dermatol (1977) 97: 371-81.
15. Gollnick H, The treatment of acne. Drugs Today (1992) 28: 353-61.
16. Goodfellow A, Alaghband-Zadeh J, Carter G et al. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Br J Dermatol (1984) 111: 209-14.
17. Chen WC, Zouboulis ChC, Orfanos CE, The 5α-reductase system and its inhibitors: recent development and its perspective in treating androgen-dependent skin disorders. Dermatology (1996) 193: 177-84.
18. Holdaway IM et al, Cyproterone acetate as initial treatment and maintenance therapy for hirsutism. Acta Endocrinol (1985) 109: 522-9.
19. Wiechert R et al, Wirkungen und Struktur neuer antiandrogener Steroide. Arzneimittelforschung (1987) 17: 1103-16.
20. Lachnit-Fixson U, The development and evaluation of an ovulation inhibitor (Diane) containing an antiandrogen. Acta Obstet Gynecol Scand Suppl (1979) 88: 33-42.
21. Carlborg L, Cyproterone acetate versus levonorgestrel combined with ethinylestradiol in the treatment of acne. Acta Obstet Gynecol Scand Suppl (1986) 134: 29-32.
22. Greenwood R, Brummitt L, Burke B et al, Acne: double blind clinical and laboratory trial of tetracycline, oestrogen cyproterone acetate and combined treatment. BMJ (1985) 291: 1231-5.
23. Nardi M, De Aloysio D, Busacchi P, Flamigni C, Cyproterone acetate-ethinylestradiol treatment of hirsutism, acne, seborrhea and alopecia. Acta Eur Fertil (1975) 6: 153-65.